Global Cancer Targeted Therapy Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cancer Targeted Therapy Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Tumor Antigens As Targets of Antibodies
  • 1.4.3 Development of Antibodies for Clinical Purposes
  • 1.4.4 Complement Dependent Cytotoxicity (CDC)
  • 1.4.5 Signal Transduction Changes
• 1.5 Market by Application
  • 1.5.1 Global Cancer Targeted Therapy Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cancer Targeted Therapy Market Size
• 2.2 Cancer Targeted Therapy Growth Trends by Regions
  • 2.2.1 Cancer Targeted Therapy Market Size by Regions (2014-2025)
  • 2.2.2 Cancer Targeted Therapy Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Cancer Targeted Therapy Market Size by Manufacturers
  • 3.1.1 Global Cancer Targeted Therapy Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Cancer Targeted Therapy Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI)
• 3.2 Cancer Targeted Therapy Key Players Head office and Area Served
• 3.3 Key Players Cancer Targeted Therapy Product/Solution/Service
• 3.4 Date of Enter into Cancer Targeted Therapy Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cancer Targeted Therapy Market Size by Type (2014-2019)
• 4.2 Global Cancer Targeted Therapy Market Size by Application (2014-2019)

5 United States

• 5.1 United States Cancer Targeted Therapy Market Size (2014-2019)
• 5.2 Cancer Targeted Therapy Key Players in United States
• 5.3 United States Cancer Targeted Therapy Market Size by Type
• 5.4 United States Cancer Targeted Therapy Market Size by Application

6 Europe

• 6.1 Europe Cancer Targeted Therapy Market Size (2014-2019)
• 6.2 Cancer Targeted Therapy Key Players in Europe
• 6.3 Europe Cancer Targeted Therapy Market Size by Type
• 6.4 Europe Cancer Targeted Therapy Market Size by Application

7 China

• 7.1 China Cancer Targeted Therapy Market Size (2014-2019)
• 7.2 Cancer Targeted Therapy Key Players in China
• 7.3 China Cancer Targeted Therapy Market Size by Type
• 7.4 China Cancer Targeted Therapy Market Size by Application

8 Japan

• 8.1 Japan Cancer Targeted Therapy Market Size (2014-2019)
• 8.2 Cancer Targeted Therapy Key Players in Japan
• 8.3 Japan Cancer Targeted Therapy Market Size by Type
• 8.4 Japan Cancer Targeted Therapy Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cancer Targeted Therapy Market Size (2014-2019)
• 9.2 Cancer Targeted Therapy Key Players in Southeast Asia
• 9.3 Southeast Asia Cancer Targeted Therapy Market Size by Type
• 9.4 Southeast Asia Cancer Targeted Therapy Market Size by Application

10 India

• 10.1 India Cancer Targeted Therapy Market Size (2014-2019)
• 10.2 Cancer Targeted Therapy Key Players in India
• 10.3 India Cancer Targeted Therapy Market Size by Type
• 10.4 India Cancer Targeted Therapy Market Size by Application

11 Central & South America

• 11.1 Central & South America Cancer Targeted Therapy Market Size (2014-2019)
• 11.2 Cancer Targeted Therapy Key Players in Central & South America
• 11.3 Central & South America Cancer Targeted Therapy Market Size by Type
• 11.4 Central & South America Cancer Targeted Therapy Market Size by Application

12 International Players Profiles

• 12.1 Advaxis
  • 12.1.1 Advaxis Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cancer Targeted Therapy Introduction
  • 12.1.4 Advaxis Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.1.5 Advaxis Recent Development
• 12.2 Bind Therapeutics
  • 12.2.1 Bind Therapeutics Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cancer Targeted Therapy Introduction
  • 12.2.4 Bind Therapeutics Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.2.5 Bind Therapeutics Recent Development
• 12.3 Boehringer Ingelheim
  • 12.3.1 Boehringer Ingelheim Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cancer Targeted Therapy Introduction
  • 12.3.4 Boehringer Ingelheim Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.3.5 Boehringer Ingelheim Recent Development
• 12.4 Bristol Mayer Squibb
  • 12.4.1 Bristol Mayer Squibb Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cancer Targeted Therapy Introduction
  • 12.4.4 Bristol Mayer Squibb Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.4.5 Bristol Mayer Squibb Recent Development
• 12.5 Celldex Therapeutics
  • 12.5.1 Celldex Therapeutics Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cancer Targeted Therapy Introduction
  • 12.5.4 Celldex Therapeutics Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.5.5 Celldex Therapeutics Recent Development
• 12.6 Dendreon Corporation
  • 12.6.1 Dendreon Corporation Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cancer Targeted Therapy Introduction
  • 12.6.4 Dendreon Corporation Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.6.5 Dendreon Corporation Recent Development
• 12.7 Eli Lily
  • 12.7.1 Eli Lily Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cancer Targeted Therapy Introduction
  • 12.7.4 Eli Lily Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.7.5 Eli Lily Recent Development
• 12.8 GalaxoSmithKline
  • 12.8.1 GalaxoSmithKline Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cancer Targeted Therapy Introduction
  • 12.8.4 GalaxoSmithKline Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.8.5 GalaxoSmithKline Recent Development
• 12.9 Galena Biopharma
  • 12.9.1 Galena Biopharma Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cancer Targeted Therapy Introduction
  • 12.9.4 Galena Biopharma Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.9.5 Galena Biopharma Recent Development
• 12.10 Genetech
  • 12.10.1 Genetech Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cancer Targeted Therapy Introduction
  • 12.10.4 Genetech Revenue in Cancer Targeted Therapy Business (2014-2019)
  • 12.10.5 Genetech Recent Development
• 12.11 ImmunoCellular Therapeutics
• 12.12 ImmunoGen
• 12.13 Inovio Pharmaceuticals
• 12.14 Johnson & Johnson
• 12.15 NeoStem Oncology
• 12.16 NewLink Genetics
• 12.17 Northwest Biotherapeutics
• 12.18 Merck
• 12.19 Novartis
• 12.20 Peregrine Pharmaceuticals
• 12.21 Pfizer
• 12.22 Roche
• 12.23 Sanofi
• 12.24 Seattle Genetics
• 12.25 Teva

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer